Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Analysts at Wolfe Research

Analysts at Wolfe Research assumed coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research note issued to investors on Monday,Briefing.com Automated Import reports. The firm set an “outperform” rating and a $29.00 price target on the stock. Wolfe Research’s price target points to a potential upside of 23.77% from the company’s current price.

Several other equities research analysts also recently weighed in on KMTS. Piper Sandler assumed coverage on Kestra Medical Technologies in a report on Monday. They set an “overweight” rating and a $27.00 price target for the company. The Goldman Sachs Group assumed coverage on shares of Kestra Medical Technologies in a research report on Monday. They set a “neutral” rating and a $24.00 price objective for the company. Stifel Nicolaus started coverage on shares of Kestra Medical Technologies in a report on Monday. They issued a “buy” rating and a $28.00 target price on the stock. Finally, Wells Fargo & Company initiated coverage on shares of Kestra Medical Technologies in a research report on Monday. They issued an “overweight” rating and a $28.00 price objective for the company. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Kestra Medical Technologies has a consensus rating of “Moderate Buy” and an average target price of $27.67.

Kestra Medical Technologies Trading Down 2.5 %

KMTS opened at $23.43 on Monday. Kestra Medical Technologies has a 52 week low of $20.00 and a 52 week high of $25.98.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.